|
|
||||||||
Department of Microbiology and Immunology, Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH 03756
Granzyme B (GZB) has been implicated as an effector mechanism in regulatory T cells (Treg) suppression. In a model of Treg-dependent graft tolerance, it is shown that GZB- deficient mice are unable to establish long-term tolerance. Moreover, mice overexpressing the inhibitor of GZB, serine protease inhibitor 6, are also resistant to tolerization to alloantigen. Graft survival was shorter in bone marrow-mixed chimeras reconstituted with GZB-deficient Treg as compared with wild-type Treg. Whereas there was no difference in graft survival in mixed chimeras reconstituted with wild-type, perforin-deficient, or Fas ligand-deficient Treg. Finally, data also show that if alloreactive effectors cannot express FoxP3 and be induced to convert in the presence of competent Treg, then graft tolerance is lost. Our data are the first in vivo data to implicate GZB expression by Treg in sustaining long-lived graft survival.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Address correspondence and reprint requests to Dr. Randolph Noelle, Department of Microbiology and Immunology, Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH 03756. E-mail address: rjn{at}dartmouth.edu
D.G. designed research, performed research, analyzed data, and wrote article V.D. performed research and reviewed the manuscript; E.N. performed research and reviewed the manuscript; L.-f.L. contributed vital tools and reviewed the manuscript; K.B. performed research and reviewed the manuscript; Z.S. contributed vital tools and reviewed the manuscript; and R.N. designed research and reviewed the manuscript.
2 Abbreviations used in this paper: DST, donor-specific transfusion; AICD, activation-induced cell death; Teff, effector t cell; Treg, regulatory T cell; nTreg, natural Treg; aTreg, adaptive Treg; GZB, granzyme B; Spi-6, serine protease inhibitor 6; Wt, wild type; Tg, transgenic; LN, lymph node; Sf, scurfin; FasL, Fas ligand.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |